| Literature DB >> 31795191 |
Silvia Lorente-Cebrián1,2, Katya Herrera3,4, Fermín I Milagro1,2,5, Juana Sánchez6,7, Ana Laura de la Garza3,4, Heriberto Castro3,4.
Abstract
Obesity prevalence is rapidly increasing worldwide. With the discovery of brown adipose tissue (BAT) in adult humans, BAT activation has emerged as a potential strategy for increasing energy expenditure. Recently, the presence of a third type of fat, referred to as beige or brite (brown in white), has been recognized to be present in certain kinds of white adipose tissue (WAT) depots. It has been suggested that WAT can undergo the process of browning in response to stimuli that induce and enhance the expression of thermogenesis: a metabolic feature typically associated with BAT. MicroRNAs (miRNAs) are small transcriptional regulators that control gene expression in a variety of tissues, including WAT and BAT. Likewise, it was shown that several food compounds could influence miRNAs associated with browning, thus, potentially contributing to the management of excessive adipose tissue accumulation (obesity) through specific nutritional and dietetic approaches. Therefore, this has created significant excitement towards the development of a promising dietary strategy to promote browning/beiging in WAT to potentially contribute to combat the growing epidemic of obesity. For this reason, we summarize the current knowledge about miRNAs and food compounds that could be applied in promoting adipose browning, as well as the cellular mechanisms involved.Entities:
Keywords: BAT; WAT; browning; food compounds; miRNAs
Mesh:
Substances:
Year: 2019 PMID: 31795191 PMCID: PMC6928892 DOI: 10.3390/ijms20235998
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Most relevant environmental, behavioral, and physiological factors that regulate white adipose tissue (WAT) browning. miRNAs, microRNAs; FGF21, Fibroblast growth factor 21; ANP, atrial natriuretic peptide; BNP, brain-type natriuretic peptide; PPAR-γ, Peroxisome proliferator-activated receptor gamma.
Figure 2MicroRNAs involved in WAT browning and beige and brown adipocyte regulation. ↑, upregulated; ↓, downregulated.
Main miRNAs involved in brown adipocyte regulation and nutritional factors that regulate their expression in human samples/cells.
| Effect on Browning | miRNA | Model and/or Tissue Sample | Nutritional Factors | Effect of the Nutritional Factor on the Expression of the miRNA | Reference |
|---|---|---|---|---|---|
|
| |||||
| 203 | Human colon adenocarcinoma cells (Caco-2) | Selenium (depletion/accurate levels) | ↓ miR-203 expression in Se depletion | [ | |
| 193b | Human plasma | Weight loss dietary treatment (RESMENA trial) | ↑ miR-193b levels (and hypomethylated) in high responders to weight loss | [ | |
| 365 | Human adipocytes | Obesity/adipose (WAT) hypertrophy | ↑ miR-365 in WAT hypertrophy | [ | |
|
| |||||
| 106b | Lung cancer cells | Seed procyanidin extract (GSE) cells | ↓ miR-106b in lung neoplastic cells | [ | |
| LT97 cells (colon adenoma cells) | Butyrate (and trichostatin A) as histone deacetylase inhibitors | ↓ miR-106b levels: affects cycle-relevant genes and thus, cell proliferation | [ | ||
| Plasma | Hyperlipidemia status/coronary artery disease (CAD) | ↓ miR-106b in patients with CAD. | [ | ||
| Human colon adenocarcinoma cells (Caco-2) | Selenium (depletion/accurate levels) | ↓ miR-106b expression in Se depletion | [ | ||
| HCT116 (colon cancer cells) | Butyrate (short chain FA) | ↓ miR-106b expression | [ | ||
| Prostate cancer cells | Resveratrol treatment | ↓ miR-106b expression | [ | ||
| 93 | Human hepatocellular carcinoma (HCC) | Nonalcoholic fatty liver disease (NAFLD) | ↑ miR-93 expression | [ | |
| Human colon adenocarcinoma cells (Caco-2) | Low-selenium environment | ↓ miR-93 expression levels in low selenium | [ | ||
| 122 | Exosomes from healthy males aged 20–30 y.o. | Fat mass/BAT activity | ↓ Exosomal miR-122-5p levels in high BAT activity group. | [ | |
| Plasma | Type 2 diabetes with/without NAFLD | ↑ miR-122 expression in T2DM patients with NAFLD as compared to those without NAFLD | [ | ||
| Serum | Breast cancer patients (survivors) with different BMI ranges (obesity, weight gain) | miR-122 expression associated with BMI | [ | ||
| Liver samples | Patients with alcoholic liver diseases (ALD) | miR-122 levels ↓ in liver samples from ALD patients | [ | ||
| Liver samples | Obese women following bariatric surgery with or without NAFLD | ↓ miR-122 in obese subjects with NAFLD | [ | ||
| Plasma | Maternal (pre-gestational and gestational) obesity | ↓ miR-122 levels in pre-gestational obesity and gestational obesity | [ | ||
| Human liver cancer cells (HepG2) | Flavonoid compounds (nobiletin, tangeretin, and hesperidin) from citrus peel | ↓ miR-122 expression and thus, affect FAS and CPT-1α, decreasing lipid accumulation | [ | ||
| Serum and plasma | Individuals with risk factors for metabolic syndrome, T2D, CVD (Bruneck study) | Circulating miR-122 associated with ↑ levels of liver enzymes, adiposity, inflammation, and insulin resistance and an adverse lipid profile Circulating miR-122 levels correlated with lipid subspecies (monounsaturated and saturated fatty acids) and cholesterol esters | [ |
↑, upregulated; ↓, downregulated.
Main miRNAs involved in brite adipocyte regulation and WAT browning and nutritional factors that regulate their expression in human samples/cells.
| Effect on Browning | miRNA | Tissue Sample | Nutritional Factor | Effect of the Nutritional Factor on the Expression of the miRNA | Reference |
|---|---|---|---|---|---|
|
| |||||
| 196a (specific) | Pancreatic cancer cells | Dietary phytochemicals (garcinol) | Modulated miR-196a expression | [ | |
| 26a/b | Formalin-fixed paraffin-embedded lung cancer (144 adenocarcinomas and 120 squamous cell carcinomas) | Intake of quercetin-rich foods (evaluated through a food-frequency questionnaire) | miR-26 expression differentially expressed between highest and lowest quercetin consumers | [ | |
| Liver (human) | HFD/obesity | ↓ miR-26 expression | [ | ||
| 32 | Healthy human colorectal epithelium | Non-digestible carbohydrates (resistant starch and polydextrose) supplementation | ↑ miR-32 expression in rectal mucosa | [ | |
| 455 | Human adipose tissue and blood cells | Obesity & T2D (computational framework miR-QTL-Scan) | BAT specific miR-455 play a role in adipogenesis | [ | |
| Human adipose tissue (BAT and WAT) from neck | HFD/Obesity and cold-induced thermogenesis | MiR-455 identified as a BAT marker in humans | [ | ||
|
| |||||
| 125-5p (specific) | Blood from T2DM and obese patients | Meta-analysis including lifestyle intervention studies | ↓ miR-125-5p in obese patients | [ | |
| 34a | Human sc WAT (48 subjects) | Three calorie-restricted diets (different amount and quality of carbohydrates): low glycemic index, high glycemic index, and low fat | ↓ miR-34a in waist circumference stratified (tertiles) cohort | [ | |
| Liver of male Sprague-Dawley rats | High-fat high-cholesterol (WD) diet supplemented with fish oil (FOH) | ↓ miR-34a in FOH vs. WD | [ | ||
| Huh-7 (human liver) cells | Cholesterol accumulation associated to nonalcoholic fatty liver disease (NAFLD) | ↑ miR-34a expression in liver | [ | ||
| 155 | THP-1 (human) monocytes/macrophages | Oleic acid | ↑ miR-155 expression in monocytes (vs. DHA) | [ | |
| 378 | Patients with NASH (liver biopsies) | N.A. | ↑ miR-378 expression | [ | |
| Muscle biopsies of healthy males | Single bout of concurrent resistance exercise (8 × 5 leg extension, 80% 1RM) + 30 min at ~70% VO2peak with either post-exercise (whey) protein (25 g) or placebo | ↑ miR-378 expression at 4 h post-exercise with protein | [ |
↑, upregulated; ↓, downregulated.
Main miRNAs involved in brown adipocyte regulation and nutritional factors that regulate their expression in animal and murine cell models.
| Effect on browning | miRNA | Tissue sample | Nutritional factor | Effect of the nutritional factor on the expression of the miRNA | Reference |
|---|---|---|---|---|---|
|
| |||||
| 196a (specific) | Adipose tissue (sc and visceral) of lambs | DHA-G diet: barley-based finishing diet where algae meal (DHA-Gold; Schizochytrium spp.) replaced flax oil | ↑ miR-196a expression in SAT vs. PAT (perirenal) in DHA-G diet. | [ | |
| Bovine adipose tissue (sc and visceral) from cattle | HFD | ↓ miR-196a in HFD and higher expression in visceral tissue depot | [ | ||
| 26a/b | Goat milk | Milk (fatty acid) composition | miR-26 expression associated with total fat yield and short-, medium and long-chain fatty acid content. | [ | |
| Liver and adipose tissue (pregnant) rats | Diets with different fatty acid types: soybean (SO), olive (OO), fish (FO), linseed (LO), or palm-oil (PO) diets from conception to day 12 of gestation and standard diet thereafter | MiR-26 (among others) differentially modulated by the different fatty acids during early pregnancy. | [ | ||
| Liver (human) & mice | HFD/obesity | ↓ miR-26 expression (humans and two obesity mice models) | [ | ||
| 30b/c | Cortex and cerebellum of middle-aged C57Bl/6J mice | Extra-virgin olive oil rich in phenols feeding for 6 months (H-EVOO, phenol dose/day: 6 mg/kg) vs. the same olive oil deprived of phenolics (L-EVOO) | ↓ miR-30 expression in H-EVOO | [ | |
| Rainbow trout eggs | Trout egg quality and production (characterization of miRNA profile) | miR-30 among top-10 most abundant miRNAs | [ | ||
| Mice adipose tissue macrophages (ATMs) | HFD (12 wk) in combination with CB1 antagonist AM251 (4 wk, 10 mg/kg) | ↑ miR-30e-5p in ATMs from HFD + AM251 mice | [ | ||
| Male C57BL/6J mice | HFD (16 wk) | ↓ miR-30a, -30c, -30e expression in ATM from HFD mice vs. NCD through epigenetic (methylation) modifications | [ | ||
| 455 | Male C57BL/6J (B6) mice | HFD (45% kcal fat) supplemented with EPA (6.75% kcal EPA) for 11 wk. | ↑ miR-455 expression in BAT | [ | |
| Murine adipose tissue (BAT and WAT) | HFD/Obesity and cold-induced thermogenesis | MiR-455 identified as a BAT marker in rodents | [ | ||
|
| |||||
| 27b | Milk samples from rats (lactation) | Cafeteria and post-cafeteria diet | MiR-27 levels in milk decrease throughout lactation. | [ | |
| Cortex and cerebellum of middle-aged C57Bl/6J mice | Extra-virgin olive oil rich in phenols feeding for 6 months (H-EVOO, phenol dose/day: 6 mg/kg) vs. the same olive oil deprived of phenolics (L-EVOO) | ↓ miR-27 levels in H-EVOO | [ | ||
| 34a | Breast cancer cells and carcinogenesis model in rats | 3,6-dihydroxyflavone (flavonoid) | ↑ miR-34a in breast carcinogenesis | [ | |
| Liver of male Sprague-Dawley rats | High-fat high-cholesterol (WD) diet supplemented with fish oil (FOH) | ↓ miR-34a in FOH vs. WD | [ | ||
| Mice liver | Three dietary interventions affecting lifespan (LS): caloric restriction (CR), low fat or high fat plus voluntary exercise or 30% CR | ↑ miR-34a in livers of two models of obesity | [ | ||
| Mouse pancreatic β-cells | Saturated fatty acids | ↑ miR-34a expression | [ | ||
| 133 | C57BL/6 male mice | High fat diet concomitant with miR-133 ASO (anti-miR-133) | ↑ miR-133 expression in HFD | [ | |
| 155 | 3T3-L1 (mouse) adipocytes | Resveratrol (25 µM) | ↑ miR-155 expression | [ | |
| FVB mice (colon mucosa) | High fat diet (45%) and 30% caloric restriction (CR) | ↑ miR-155 expression in colon mucosa in HFD mice | [ | ||
| RAW264.7 macrophages (LPS activated) | 10 µM quercetin, quercetin-3-glucuronide (Q3G) and isorhamnetin | ↓ miR-155 expression by quercetin and Q3G | [ | ||
| 378 | Livers of dietary obese mice | HFD (60% cal.) | ↑ miR-378 expression | [ | |
| Milk samples from dairy cows in mid lactation | Control diet (total mixed ration of corn:grass silages) for 28 days followed by a treatment period (control diet supplemented with 5% linseed or safflower oil) of 28 days. | ↑ miR-378 expression by both treatments | [ | ||
| Mice livers | Fasting & re-feed | ↑ miR-378 expression in fasting & ↓ miR-378 upon re-feeding | [ | ||
| Mice liver | Fisetin (a flavonoid): normal diet, HFD, HFD + fisetin | ↑ miR-378 expression by HFD & ↓ miR-378 by fisetin sup. | [ | ||
| Mice brown adipocytes | Omega-3 eicosapentaenoic acid (EPA) | ↑ miR-378 expression by EPA during brown differentiation | [ |
↑, upregulated; ↓, downregulated.
Figure 3Food compounds and activated genes involved in WAT browning. Fgf21, Fibroblast growth factor 21; Tmem26, Transmembrane protein 26; Pparγ, Peroxisome proliferator-activated receptor gamma; Pparα, Peroxisome proliferator-activated receptor α; Cidea, Cell death inducing DFFA like effector A; Prmd16, PR-domain containing 16; Pgc-1α, Peroxisome proliferator-activated γ receptor co-activator 1 alpha; Ucp-1, Uncoupling protein-1.